Axsome Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.
AXSM Key Statistics
Stock Snapshot
Axsome Therapeutics(AXSM) stock is priced at $223.92, giving the company a market capitalization of 11.43B. It carries a P/E multiple of -60.55.
On 2026-05-05, Axsome Therapeutics(AXSM) stock opened at $209.00, reached a high of —, and a low of —.
The Axsome Therapeutics(AXSM)'s current trading volume is 1.27K, compared to an average daily volume of 958.38K.
During the past year, Axsome Therapeutics(AXSM) stock moved between $96.09 at its lowest and $234.29 at its peak.
During the past year, Axsome Therapeutics(AXSM) stock moved between $96.09 at its lowest and $234.29 at its peak.
AXSM News
Axsome Therapeutics Inc. ((AXSM)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level dat...
Reports Q1 revenue $191.2M, consensus $190.69M. “Axsome had a tremendous start to 2026. Our commercial business delivered robust year-over-year growth in the fi...
Axsome Therapeutics recently announced that the U.S. FDA has approved AUVELITY, a first-in-class oral NMDA receptor antagonist and sigma-1 agonist, to treat agi...
Analyst ratings
91%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.